相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans CSF AD biomarkers measured by Lumipulse in Koreans
Sohee Moon et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest
Farida Dakterzada et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
June Kaplow et al.
ALZHEIMERS & DEMENTIA (2020)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
Ashvini Keshavan et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Arnyloid1-42 measurement
Chiara Zecca et al.
CLINICA CHIMICA ACTA (2019)
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis
Silvia Paciotti et al.
CLINICA CHIMICA ACTA (2019)
Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer's disease diagnosis
Jean-Louis Bayart et al.
JOURNAL OF NEUROLOGY (2019)
What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
Emmanuel Cognat et al.
BMJ OPEN (2019)
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
Daniel Alcolea et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease
Maria Joao Leitao et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic
Katerina Sheardova et al.
BMJ OPEN (2019)
Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity
Gael Barthet et al.
NATURE COMMUNICATIONS (2018)
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine
Davide Chiasserini et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
mixtools: AnRPackage for Analyzing Finite Mixture Models
Tatiana Benaglia et al.
Journal of Statistical Software (2015)
Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid
Andreas Leinenbach et al.
CLINICAL CHEMISTRY (2014)
Longitudinal Stability of Cerebrospinal Fluid Biomarker Levels: Fulfilled Requirement for Pharmacodynamic Markers in Alzheimer's Disease
Nathalie Le Bastard et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
分享论文
